Search results for "Oncogene"

showing 10 items of 1005 documents

Molecular Characterization of Relapsed Core-Binding Factor (CBF) Acute Myeloid Leukemia (AML)

2015

Abstract Background: CBF-AML is defined by recurrent genetic abnormalities which encompass t(8;21)(q22;q22), inv(16)(p13.1q22) or less frequently t(16;16)(p13.1;q22). Most frequent secondary chromosome aberrations in t(8;21) AML are del(9q) or loss of a sex chromosome, and in inv(16)/t(16;16) AML trisomy 22 or trisomy 8. At the molecular level mutations involving KIT, FLT3, or NRAS were identified as recurrent lesions in CBF-AML. However, the underlying genetic alterations which might trigger relapse in CBF-AML are not well delineated. Thus, the aim of our study was to characterize the clonal architecture of relapsed CBF-AML. Methods: We performed mutational profiling (KIT, FLT3-ITD, FLT3-T…

Neuroblastoma RAS viral oncogene homologOncologymedicine.medical_specialtybusiness.industryImmunologyMyeloid leukemiaCell BiologyHematologyKit mutationCore binding factorBioinformaticsTrisomy 8medicine.diseaseBiochemistryExonInternal medicineChromosome abnormalityMedicinebusinessTrisomyBlood
researchProduct

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma

2013

Background Tumor models are critical for our understanding of cancer and the development of cancer therapeutics. Here, we present an integrated map of the genome, transcriptome and immunome of an epithelial mouse tumor, the CT26 colon carcinoma cell line. Results We found that Kras is homozygously mutated at p.G12D, Apc and Tp53 are not mutated, and Cdkn2a is homozygously deleted. Proliferation and stem-cell markers, including Top2a, Birc5 (Survivin), Cldn6 and Mki67, are highly expressed while differentiation and top-crypt markers Muc2, Ms4a8a (MS4A8B) and Epcam are not. Myc, Trp53 (tp53), Mdm2, Hif1a, and Nras are highly expressed while Egfr and Flt1 are not. MHC class I but not MHC class…

Neuroblastoma RAS viral oncogene homologmedicine.disease_causeMajor histocompatibility complexPolymorphism Single NucleotideProto-Oncogene Proteins p21(ras)TranscriptomeMiceAntigenAntigens NeoplasmCDKN2ACell Line TumorMHC class ImedicineGeneticsAnimalsCancer modelsComputational immunologyCyclin-Dependent Kinase Inhibitor p16Mice Inbred BALB CMHC class IIbiologyCarcinomaHigh-Throughput Nucleotide SequencingSequence Analysis DNAColorectal cancerMolecular biologyColonic Neoplasmsbiology.proteinImmunotherapyKRASTranscriptomeResearch ArticleBiotechnologyBMC Genomics
researchProduct

The Pvt-1 oncogene is a target of Myc and its expression is deregulated in neuroblastoma cells

2003

NeuroblastomaPvt-1MycOncogene
researchProduct

Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas

2012

Neuroblastoma is an aggressive embryonal tumor that accounts for similar to 15% of childhood cancer deaths. Hitherto, despite the availability of comprehensive genomic data on DNA copy number changes in neuroblastoma, relatively little is known about the genes driving neuroblastoma tumorigenesis. In this study, high resolution array comparative genome hybridization (CGH) was performed on 188 primary neuroblastoma tumors and 33 neuroblastoma cell lines to search for previously undetected recurrent DNA copy number gains and losses. A new recurrent distal chromosome 1q deletion (del(1)(q42.2qter)) was detected in seven cases. Further analysis of available array CGH datasets revealed 13 additio…

Neuroblastoma/geneticsCancer ResearchProcollagen-Proline DioxygenaseMedizinGene Dosagecomparative genomic hybridizationBiologymedicine.disease_causeGene dosageN-Myc Proto-Oncogene ProteinFumarate HydrataseHypoxia-Inducible Factor-Proline DioxygenasesNeuroblastomaProcollagen-Proline Dioxygenase/geneticsCell Line TumorNeuroblastomamedicineHumansFumarate Hydratase/geneticsGeneOncogene ProteinsGeneticsN-Myc Proto-Oncogene ProteinChromosomes Human Pair 11BreakpointNuclear ProteinsChromosomemedicine.diseaseOncogene Proteins/geneticsNuclear Proteins/geneticsOncologyChromosome DeletionCarcinogenesisComparative genomic hybridization
researchProduct

Reply to "More evidence that genetic profiling will delineate the nosology and biologic potential of fibrohistiocytic tumors in the dermatofibrosarco…

2013

NosologyMalemedicine.medical_specialtyPathologySkin NeoplasmsOncogene Proteins Fusionbusiness.industryDermatofibrosarcomaDermatologymedicine.diseaseDermatologyDermatofibrosarcoma protuberansMedicineHumansFemalebusinessJournal of the American Academy of Dermatology
researchProduct

Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of…

2021

Abstract Approaches to improve pancreatic cancer therapy are essential as this disease has a very bleak outcome. Approximately 80% of pancreatic cancers are pancreatic ductal adenocarcinomas (PDAC). A key regulatory gene frequently mutated (∼75%) in PDAC is the TP53 tumor suppressor gene which controls the transcription of multiple genes involved in cell cycle progression, apoptosis, cancer progression and other growth regulatory processes. The mouse double minute 2 homolog (MDM2) gene product is a nuclear-localized E3 ubiquitin ligase and negatively regulates the TP53 protein which results in its proteasomal degradation. Various MDM2 inhibitors have been isolated and examined in clinical t…

Nutlin-3aCancer ResearchBerberineendocrine system diseasesTumor suppressor geneNAX compoundsApoptosisPiperazinesTargeted therapyGene productCell Line TumorPancreatic cancerGeneticsmedicineHumansTP53neoplasmsMolecular BiologyRegulator geneNAX compundsbiologyChemistryImidazolesPDACCancerProto-Oncogene Proteins c-mdm2PDCAmedicine.diseaseUbiquitin ligasePancreatic NeoplasmsCell culturebiology.proteinCancer researchNAX compoundMolecular MedicineMdm2Tumor Suppressor Protein p53Signal TransductionAdvances in Biological Regulation
researchProduct

Subcellular distribution of ras in human and murine fibroblasts.

1996

Abstract Ras proteins play a significant role in signal transduction in response to growth factors and in cell transformation. To be active, ras has to be translocated to the cell membrane. Since subcellular distribution has been mainly studied in vector-transformed cells which highly express ras proteins, and it has been difficult to detect ras in cells expressing the protein at physiological levels, we studied subcellular distribution in human and murine fibroblasts. Here we show for the first time that a significant amount of ras is associated with the membrane skeleton and the cytoskeleton.

OctoxynolDetergentsBiophysicsBiologyOncogene Protein p21(ras)BiochemistryCell LinePolyethylene GlycolsCell membraneMicemedicineAnimalsHumansCytoskeletonMolecular BiologyCell Line TransformedMice Inbred C3HCell BiologyFibroblastsCell biologyTransformation (genetics)Subcellular distributionMembranemedicine.anatomical_structureSignal transductionSubcellular FractionsBiochemical and biophysical research communications
researchProduct

Bilateral olfactory deprivation reveals a selective noradrenergic regulatory input to the olfactory bulb.

2001

Unilateral olfactory deprivation in the rat induces changes in the catecholaminergic system of the olfactory bulb. Nevertheless, evidence suggests that unilateral deprivation does not fully prevent stimulation of the deprived bulb. The present report analyses the response of the catecholaminergic system of the olfactory bulb in fully deprived rats obtained by bilateral naris occlusion. The complete deprivation produces more rapid and dramatic changes in both the intrinsic and extrinsic catecholaminergic systems of the olfactory bulb. Intrinsic responses involve a rapid decrease in dopamine-containing cells to about 25% of controls, correlated with a decreased Fos expression in juxtaglomerul…

Olfactory systemOlfactory NerveTyrosine 3-MonooxygenaseDopamineCentral nervous systemOlfactionDopamine beta-HydroxylaseBiologyNorepinephrinemedicineAnimalsSensory deprivationOlfactory memoryRats WistarCatecholaminergicAfferent PathwaysNeuronal PlasticityGeneral NeuroscienceOlfactory tubercleDenervationOlfactory BulbAxonsOlfactory bulbRatsSmellOlfactory Nerve Injuriesmedicine.anatomical_structureFemaleLocus CoeruleusSensory DeprivationNeuroscienceProto-Oncogene Proteins c-fosNeuroscience
researchProduct

Prognostic value of SOX2 expression in neuroblastoma.

2010

Oncogene ProteinsCancer ResearchN-Myc Proto-Oncogene Proteinbusiness.industrySOXB1 Transcription FactorsValue (computer science)InfantNuclear ProteinsBiologyExpression (computer science)medicine.diseasePrognosisN-Myc Proto-Oncogene ProteinNeuroblastomaText miningSOX2NeuroblastomaGeneticsCancer researchmedicineHumansbusinessGenes, chromosomescancer
researchProduct

Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.

1995

AbstractWe have synthesized capsid proteins of human papillomavirus types 6 (HPV 6) and 16 (HPV 16) in fission yeast Schizosaccharomyces pombe and produced virus-like particles (VLP). The capsid proteins were localized in the nucleus by indirect immunofluorescence and cell fractionation analyses. The VLP were produced in both yeast clones synthesizing L1 alone and L1/L2 and purified by sulfato-cellulofine chromatography. Electron microscopic examination showed that these VLP were similar in structure to native HPV particles. Two HPV 16 L1 variants (16 B27L1 and 16 T3L1), isolated from benign cervical samples, produced many more (68- and 14-fold) VLP than the prototype L1 (16 PL1) derived fr…

Oncogene ProteinsImmunoprecipitationvirusesMolecular Sequence DataBiologyVirusSepharoseViral ProteinsCapsidVirologySchizosaccharomycesCloning MolecularPapillomaviridaeDNA PrimersBase SequenceVirionvirus diseasesOncogene Proteins Viralbiology.organism_classificationMolecular biologyYeastRecombinant ProteinsMicroscopy ElectronCapsidSchizosaccharomyces pombeCapsid ProteinsCell fractionationVirology
researchProduct